Back to company

CONRIG PHARMA ApS: Financial statements 2014

CVR: 33373236

CONRIG PHARMA ApS (CVR 33373236) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -92,788 and a net result of DKK -81,341 compared with DKK -274,036 the year before. Equity amounted to DKK 94,066. The solvency ratio was 45.1%.

Gross Profit
-92,788 kr.
Profit/Loss
-81,341 kr.
Equity
94,066 kr.
Total Assets
208,794 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014--93 t.-81 t.94 t.-
2013--228 t.-274 t.276 t.-
2012--266 t.-244 t.200 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on CONRIG PHARMA ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2014

CONRIG PHARMA ApS: The 2013 annual report is outMay 27, 2014

CONRIG PHARMA ApS has published its annual report for 2013. Gross profit came to DKK -227,519, and the net result was DKK -274,036.

About CONRIG PHARMA ApS

CONRIG PHARMA ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Snickar Karl Johan Tobieson and Lars Christer Fredrik Fåhraeus. The company is owned by Melius Pharma AB. The company has 0 employees. In 2025, the company reported a gross profit of DKK -98,936 and a net result of DKK -95,786 compared with DKK -100,217 the year before. Equity amounted to DKK 0.